induced pluripotent stem cell

(redirected from Induced Pluripotent Stem)

induced pluripotent stem cell

,

iPS

A body cell that has been reprogrammed to behave like an embryonic stem cell, that is, to be able to differentiate into cells that could regenerate and repair many different kinds of damaged or diseased tissues.
Mentioned in ?
References in periodicals archive ?
10,370,452 covering compositions and uses of effector T cells expressing a chimeric antigen receptor, where such T cells are derived from a pluripotent stem cell including an induced pluripotent stem cell.
Induced pluripotent stem cells (iPSCs) are generated from adult cells that are reprogrammed to enable the development of an unlimited source of any type of human cell needed, which allows researchers to model diseases in a dish.
While there are several promising types of stem cells under investigation for wound healing, in the March issue of Stem Cell Research and Therapy, a team of researchers zeroed in on one up-and-coming option: induced pluripotent stem cells.
Public health england (phe) is seeking to procure an external service provider that can assess the chromosomal stability of human induced pluripotent stem cells (ipscs).
They cover induced pluripotent stem-cell-derived cardiomyocytes (iPSC-CMs) as a novel diagnostic platform; preclinical large-animal models of cardiovascular regeneration; cell-free therapy with stem cell secretions: protection, repair, and regeneration of the injured myocardium; myoblasts as treatment for hereditary muscular dystrophies, cardiomyopathies, type 2 diabetes, solid tumors, and aging; stem cells in ophthalmology; stem cells for ocular therapies; cell therapy for liver regeneration; patient-specific induced pluripotent stem cells for cardiac disease modeling; and the role of stem cells in evolution: a hypothesis.
The researchers transplanted human induced pluripotent stem cell (iPSC)-derived GABAergic progenitor cells into the hippocampus in an animal model of early temporal lobe epilepsy.
There is another category called induced pluripotent stem cells (iPSCs).
- Cambridge, Massachusetts-based biotech company Platelet BioGenesis has licensed patents related to induced pluripotent stem cells (iPS cells) from iPS Academia Japan's patent portfolio, the company said.
Objective: Since the advent of induced pluripotent stem cell (iPSC) technology a decade ago, enormous progress has been made in stem cell biology and regenerative medicine.
MSCs induced from pluripotent stem cells (PSCs), such as embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), could provide such a source.
INDUCED PLURIPOTENT STEM Cells (IPSCs) are a kind of adult cells that have been genetically reprogrammed to become different cell types.
It was reported on Thursday that the collaboration is immediately aimed at generating induced pluripotent stem cell lines for use in support of the company's discovery efforts focused on new medicines for neurodegenerative diseases.